AMRI expertly conducts chiral resolution services within all phases of the drug development process. With an extensive chiral method development platform using HPLC and SFC, we develop chromatographic methods for scale-up to preparative applications. The in-house inventory of chiral stationary phases (CSP) in bulk and packed columns for SFC and HPLC correlates to the wide array of CSP screened during method development. Our scientists conduct resolution of gram to kilogram quantities of racemates on a regular basis for research and nonclinical safety studies.
The combination of SFC and HPLC technology for chiral applications enables us to deliver throughput, efficiency and quality on each process.